Valence 로고
인기
로그인

관심목록에 추가

Mangoceuticals Inc.

NasdaqCM: MGRX · 실시간 가격 · USD
0.53
+0.00 (0.00%)
종가 기준: Aug 18, 2026, 12:13 PM

Mangoceuticals Inc. (MGRX) Stock Price, Analysis & Data

0.00%
매수호가n/a
시가총액9.17M
매출 (ttm)n/a
순이익 (ttm)n/a
베타n/a
EPS (ttm)n/a
P/E (ttm)n/a
선행 P/En/a
P/B (ttm)0.67
P/S (ttm)n/a
Earnings Daten/a
매도호가n/a
거래량21,113,248
평균 거래량 (20일)
시가0.58
전일 종가0.53
일중 범위0.47 - 0.60
52주 범위0.16 - 2.75
애널리스트n/a
목표주가n/a
배당n/a
배당락일n/a

MGRX 소개

A detailed description of the company is not yet available....

[더 보기]
산업 n/a
섹터 n/a
IPO 일자 Mar 21, 2023
직원 수 n/a
상장 거래소 NasdaqCM
티커 MGRX
전체 기업 정보

재무 실적

2025년 Mangoceuticals의 매출은 456.02K로, 전년 615.87K 대비 -25.96% 감소했습니다. 순이익은 -20.64M로, 137.11% 증가했습니다.

재무제표
news image

4개월 전 · Associated Press Finance

BC-Most Active Stocks

Nu Holdings Ltd. 74,509,403 14.92

news image

8개월 전 · MT Newswires

Top Midday Decliners

Mangoceuticals (MGRX) reported Friday the closing of its registered direct offering and concurrent p

news image

9개월 전 · Pharmaceutical Technology

Eli Lilly and Novo Nordisk disown Mangoceuticals’ GLP-1RA partnership claim

The two drugmakers swiftly denied any affiliation with Mangoceuticals, who claimed it had partnered with them.

news image

9개월 전 · Reuters

Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs

By Christy Santhosh (Reuters) -Novo Nordisk and Eli Lilly denied weight-loss drug partnership with Mangoceuticals on Thursday, hours after the telehealth provider disclosed it had arrangements with